ClinConnect ClinConnect Logo
Search / Trial NCT06995638

Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study

Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · May 21, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Aging Cognition Executive Functions Randomized Controlled Trial Cognitive Training Neuropsychology

ClinConnect Summary

The MUST Study is a research project aimed at helping older adults aged 60 to 75 improve their thinking and multitasking skills. As we age, our ability to manage multiple tasks at once can decline, which may lead to issues like cognitive decline or even Alzheimer's disease. This study will look at whether playing a special online game called the Breakfast Game can help enhance these important skills in healthy older adults. To participate, individuals will need to complete some health questionnaires, a cognitive assessment (a simple test to check thinking skills), and a blood test.

Participants will attend two in-person sessions and then take part in an educational session about healthy aging, followed by ten one-hour online training sessions over a month. After completing the program, participants will take the cognitive assessment again to see if there have been any improvements, with follow-up assessments three months later. It's important to note that people with certain cognitive impairments or health conditions may not be eligible for this study. Overall, this trial aims to find effective ways to support healthy aging and improve cognitive function in older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 60-75
  • Adequate English proficiency
  • * Willingness to adhere to training protocol:
  • Attend 2 in-person assessments
  • Attend a blood test
  • Attend online intervention sessions and online follow-up assessment
  • Exclusion Criteria:
  • Low test scores (below 26 on the Montreal Cognitive Assessment)
  • Known history of cognitive impairment, dementia, stroke, seizure disorder, or other neuropsychiatric condition judged to impact cognitive performance.
  • Taking medications known to influence cognitive performance.
  • Sensory (e.g. visual, auditory) or physical (e.g. severe arthritic, orthopedic, neurologic) impairment incompatible with use of a standard computer workstation.
  • Enrolled in a concurrent study that could affect the outcome of this study.

About Rutgers, The State University Of New Jersey

Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.

Locations

Newark, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Sharon Sanz Simon Assistant Professor, Ph.D.

Principal Investigator

Rutgers University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported